← All companies
B
BioXcel Therapeutics, Inc.
BTAI - Company ID 0001720893
Market cap-
Rank-
Filings656
BioXcel Therapeutics, Inc. has filed 656 public company documents between 2017 and 2026. The most frequent type is insider trade (225 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Continue researchBTAI overviewCompany snapshotMarket cap, financials, charts, and latest company context.
Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.
Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.
Continue researchCompare with LLYPeer viewPut BTAI beside LLY across market cap, revenue, income, and filings.
Similar companies to research next
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.